The In Vitro and In Vivo Effects of Alginate on Immune Response in Model Systems

Abstract

The use of polymeric biomaterials in regenerative medicine and drug delivery is a continually growing practice. Alginic acid (alginate) is widely used in these fields because of its beneficial properties from an engineering and mechanical perspective. Still, alginate has not yet been fully investigated from a biological perspective. For disciplines that anticipate in vivo use of their devices, it is crucial to understand the biological interactions between the device and the host. In this project, the in vitro and in vivo immunological effects of alginate are examined in two model systems: one with a protein antigen and one with a xenogeneic cell antigen. The former system is used as a proof of principle study for alginate's immunological effect on simple protein-based systems, similar to those found in protein/drug deli very applications and certain types of vaccines. This model uses bovine serum albumin (BSA) as the protein antigen. The latter system is used to demonstrate alginate's effect on more complex antigens, such as whole cells. Thus, Chinese hamster ovary (CHO) cells are used as the as the cell antigen. This model represents a system that may be found in tissue engineering applications, where whole cells are delivered with a biomaterial scaffold. Antibody production from blood serum indicated that alginate solution has adjuvant abilities while alginate microspheres do not. Thus, alginate solution possesses great potential in the field of vaccines. In addition, in vivo alginate challenges were found to have effects on second-set responses of splenocytes to in vitro alginate and antigen challenges. Splenocytes from alginate-injected mice were overall equally or less responsive to in vitro challenges than splenocytes without previous alginate immunization. Therefore, alginate solution may also have immunosuppressive effects, although the results from this project merely speculate on this possibility. Still, this ability would be helpful in overcoming current transplantation problems as well as certain tissue engineering hurdles.